ACC and AHA updated their recommendations on statins in 2026

For patients with clinically significant atherosclerotic cardiovascular disease and a very high risk of recurrence, a threshold of less than 55 mg/dL has been defined.

This change fundamentally alters the approach to conducting any discussions about statins as part of secondary prevention.

 

A 2026 meta‑analysis found no evidence that statin therapy causes most of the side effects listed in statin prescribing information, including memory loss, depression, sleep disorders, erectile dysfunction, fatigue, and headache.

 

Fulltext of recommendations

Scientific news

  • Weight Loss During Heart Failure Hospitalization Linked to Lower 30-Day Rehospitalization Risk Patients hospitalized for heart failure who were treated with intravenous loop diuretics and achieved a weight loss of at least 2 kg between admission and discharge had a reduced risk for HF rehospitalization within 30 days.
  • Allergic vasospastic angina: a systematic review Allergic vasospastic angina (also known as Kunis syndrome) is a little‑studied subtype of vasospastic angina in which spasm of the coronary arteries is triggered by an allergen. Scientists conducted a study in which they assessed the clinical characteristics, mechanisms, and treatment methods for this interesting subtype of angina.
  • Fitness Changes Over Time Linked to Cardiovascular Risk A large UK Biobank analysis showed that even a small annual improvement in cardiorespiratory fitness among adults was independently associated with lower risks for incident cardiovascular disease and cardiovascular mortality, whereas declining fitness was linked to a progressively higher risk in a clear dose-dependent pattern.
  • Cardioprotection Rarely Used in Adults With Blood Cancers In a US cohort study of adults on anthracycline-based therapy for hematologic cancers, only 1%-2% received strategies to lower the risk for treatment-related heart damage.
  • New horizons of cardiotherapy Since the introduction of the first implantable stimulator and defibrillator (ICD), cardiological science has advanced far. ICDs are highly effective, but their main disadvantage is the complications associated with the electrodes. To avoid the need for venous access and complications caused by transvenous electrodes, a fully subcutaneous ICD system (pc-ICD) was developed.

Partners

Video resource

Channel "Cardioprogress"

Follow us

Top.Mail.Ru